Brief: Novocure Announces Positive Topline Results From Phase 3 Panova-3 Clinical Trial Of Tumor Treating Fields Therapy For Pancreatic Cancer

NovoCure

02/12/2024 12:00

Dec 2 (Reuters) - Novocure Ltd  NVCR.O :
    * NOVOCURE: POSITIVE TOPLINE RESULTS FROM PHASE 3 PANOVA-3
CLINICAL TRIAL OF TUMOR TREATING FIELDS (TTFIELDS) THERAPY FOR
PANCREATIC CANCER
    * NOVOCURE: PLANS TO FILE FOR REGULATORY APPROVAL IN THE
U.S., EU,
JAPAN AND OTHER KEY MARKETS
    * NOVOCURE: TTFIELDS THERAPY WAS WELL-TOLERATED, SAFETY WAS
CONSISTENT WITH PRIOR CLINICAL STUDIES
    * NOVOCURE: PANOVA-3 TRIAL MET PRIMARY ENDPOINT, SHOWS
SIGNIFICANT
SURVIVAL IMPROVEMENT

Source text:  ID: 
Further company coverage:  NVCR.O 

 ((Reuters.Briefs@thomsonreuters.com))